[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $espr Esperion Therapeutics ($ESPR) sees mixed signals as buyout rumors and Japan approval fuel optimism, but the recent public offering is causing some downward pressure. The stock is re-rating before our eyes. ### About $espr Esperion Therapeutics ($ESPR) is a pharmaceutical company focused on developing and commercializing oral, once-daily, non-statin therapies for the treatment of hypercholesterolemia. ### Engagements: XXX [#](/topic/$espr/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$espr/time-series/interactions.tsv) **Current Value**: XXX **Daily Average**: XXXXX **1 Week**: XXXXXX -XX% **1 Month**: XXXXXXX -XX% **1-Year High**: XXXXXX on 2025-08-04 **1-Year Low**: XX on 2025-09-15 | Social Network | X | YouTube | | -------------- | - | ------- | | Engagements | XXX | XX | ### Mentions: XX [#](/topic/$espr/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$espr/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XX **1-Year High**: XXX on 2025-06-28 **1-Year Low**: X on 2025-09-15 | Social Network | X | YouTube | | -------------- | - | ------- | | Mentions | XX | X | ### Creators: XX [#](/topic/$espr/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$espr/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning $espr in the last XX hours which is down XX% from XX in the previous XX hours **Daily Average**: XX **1-Year High**: XXX on 2025-06-28 **1-Year Low**: X on 2025-09-15 The most influential creators that mention $espr in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@MACROVET888](/creator/twitter/MACROVET888) | X | XXX | X | XX | | [@Bbrc424864Bbrc](/creator/twitter/Bbrc424864Bbrc) | X | XXX | X | XX | | [@stocket_rocket](/creator/twitter/stocket_rocket) | X | XXX | X | XX | | [@msp12389](/creator/twitter/msp12389) | X | XXXXX | X | XX | | [@BuyTheUgly](/creator/twitter/BuyTheUgly) | X | XX | X | XX | | [@rumourbuyouts](/creator/twitter/rumourbuyouts) | X | XXX | X | XX | | [@mariostario2019](/creator/twitter/mariostario2019) | X | XX | X | XX | | [@TradershubNinja](/creator/twitter/TradershubNinja) | X | XXXXX | X | X | | [@ChirpSavvy](/creator/twitter/ChirpSavvy) | X | XXX | X | X | [View More](/list/creators/$espr/100) ### Sentiment: XXX% [#](/topic/$espr/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$espr/time-series/sentiment.tsv) **Current Value**: XXX% **Daily Average**: XX% **1 Week**: XXX% no change **1 Month**: XXX% +25% **1-Year High**: XXX% on 2025-04-27 **1-Year Low**: XX% on 2025-09-29 **Most Supportive Themes** - **Buyout Speculation and Price Targets:** (40%) Positive sentiment around potential buyout offers from Otsuka, with analysts setting a $X price target. - **Japan Approval and Patent News:** (30%) Positive sentiment around the Japan approval and the potential for a triple-combo patent. - **Patent Approval:** (20%) Positive sentiment around the potential for a triple-combo patent. **Most Critical Themes** - **Financial Strategy and Inventory Management:** (10%) Concerns about potential delays in revenue recognition and the impact of inventory management on cash flow. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXX | XX% | XXX | XX% | X | X% | | YouTube | X | X% | XX | X% | X | X% | | | | | | | | | | Total | XXX | XX% | XXX | XX% | X | X% | **Top assets mentioned** In the posts about $espr in the last XX hours [Dave Inc. Class A Common Stock (DAVE)](/topic/$dave) [Moonft (MTC)](/topic/$mtc) [NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)](/topic/$nams) [Agilon Health, Inc. (AGL)](/topic/agilon-health-inc) [Agilon Health, Inc. (AGL)](/topic/$agl) [Elanco Animal Health Incorporated Common Stock (ELAN)](/topic/$elan) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Landwolf (WOLF)](/topic/$wolf) [Jigstack (STAK2)](/topic/jigstack) [AST SpaceMobile, Inc. Class A Common Stock (ASTS)](/topic/$asts) **Top topics mentioned** In the posts about $espr in the last XX hours [coins made in usa](/topic/coins-made-in-usa), [$gsun](/topic/$gsun), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$4578t](/topic/$4578t), [discord](/topic/discord), [$dave](/topic/$dave), [$4768t](/topic/$4768t), [$mtc](/topic/$mtc), [coins defi](/topic/coins-defi), [japan](/topic/japan), [stocks healthcare](/topic/stocks-healthcare), [$cmnd](/topic/$cmnd), [$nams](/topic/$nams), [lack of](/topic/lack-of), [acquisition](/topic/acquisition), [agilon health inc](/topic/agilon-health-inc), [$agl](/topic/$agl), [$sgd](/topic/$sgd), [coins layer 1](/topic/coins-layer-1), [$elog](/topic/$elog), [$120m](/topic/$120m), [$elan](/topic/$elan), [$crsp](/topic/$crsp), [$wolf](/topic/$wolf), [$benf](/topic/$benf), [jigstack](/topic/jigstack), [coins dao](/topic/coins-dao), [momentum](/topic/momentum), [united states](/topic/united-states), [$asts](/topic/$asts), [$tmq](/topic/$tmq), [$pubm](/topic/$pubm), [$hoth](/topic/$hoth), [$spy](/topic/$spy), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$zbio](/topic/$zbio), [primary market](/topic/primary-market), [flood](/topic/flood), [cracks](/topic/cracks), [$107m](/topic/$107m), [$114m](/topic/$114m), [disco](/topic/disco), [$xbi](/topic/$xbi), [liver](/topic/liver), [uptrend](/topic/uptrend), [up the](/topic/up-the), [bump](/topic/bump), [$phat](/topic/$phat), [$300m](/topic/$300m), [ipo](/topic/ipo), [$mrm](/topic/$mrm), [$papl](/topic/$papl), [$htfl](/topic/$htfl), [coins bsc](/topic/coins-bsc), [stocks technology](/topic/stocks-technology), [stocks industrials](/topic/stocks-industrials), [$aapl](/topic/$aapl), [$aep](/topic/$aep), [$colb](/topic/$colb), [insurance](/topic/insurance), [$450m](/topic/$450m), [money](/topic/money), [wall street](/topic/wall-street), [ecomi](/topic/ecomi), [coins base ecosystem](/topic/coins-base-ecosystem), [coins nft](/topic/coins-nft), [coins gaming](/topic/coins-gaming), [$omi](/topic/$omi), [$poet](/topic/$poet), [$prgo](/topic/$prgo), [$slrx](/topic/$slrx), [$490s](/topic/$490s), [$upc](/topic/$upc), [$xbio](/topic/$xbio), [$acxp](/topic/$acxp), [$tgtx](/topic/$tgtx), [$rcat](/topic/$rcat), [$onds](/topic/$onds), [shah](/topic/shah), [$hubc](/topic/$hubc), [$spcb](/topic/$spcb), [$bidu](/topic/$bidu), [baidu](/topic/baidu), [$9888hk](/topic/$9888hk), [$peng](/topic/$peng), [coins meme](/topic/coins-meme), [$imxi](/topic/$imxi), [$sprb](/topic/$sprb), [$50m](/topic/$50m), [$kpti](/topic/$kpti), [$rnaz](/topic/$rnaz), [listing](/topic/listing), [china](/topic/china), [$dgnx](/topic/$dgnx), [$ntla](/topic/$ntla), [$apge](/topic/$apge), [$crml](/topic/$crml), [$200m2b](/topic/$200m2b), [$kytx](/topic/$kytx), [$phoe](/topic/$phoe) ### Top Social Posts [#](/topic/$espr/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$ESPR Management insisted the cash runway was solidclearly not. Lack of transparency is business as usual for this team. Either it was a poison pill to block a takeover or once the offering killed it they chose litigation instead" [X Link](https://x.com/Blueeee_Jay/status/1979291929968853341) [@Blueeee_Jay](/creator/x/Blueeee_Jay) 2025-10-17T21:02Z XXX followers, XXX engagements "$ESPR Sober Reflections Without Drama But Worth Considering These thoughts are prompted by several recent developments. On September XX 2025 BA received approval in Japan. According to the agreement Otsuka were to pay $XX million jupon first JNDA and up to $XX million upon achivement events "MACE" (see screenshot and details pricing-related milestones following inclusion on the NHI list). The payment timeline for these milestones is typically XX months after the event which implies a latest due date around November XX. Then we received the encouraging news about the Dr. Reddys settlement" [X Link](https://x.com/AndriiMart1/status/1979277291416097023) [@AndriiMart1](/creator/x/AndriiMart1) 2025-10-17T20:04Z XX followers, 1002 engagements "$ESPR soaked up the new share offering better than anticipated. Looks like we bump up against $XXXX -$3.50 once or twice more. Then run towards $XXXX. The stock is re-rating before our eyes" [X Link](https://x.com/Bbrc424864Bbrc/status/1979272042513142204) [@Bbrc424864Bbrc](/creator/x/Bbrc424864Bbrc) 2025-10-17T19:43Z XXX followers, XXX engagements "$ESPR $XBI ESPR starts selection ACLY for rare liver condition with potential Orphan Drug Status but more near term catalysts. As mentioned with past posts the new uptrend has started despite market instability. It is safe extremely undervalued" [X Link](https://x.com/MACROVET888/status/1979190924778283279) [@MACROVET888](/creator/x/MACROVET888) 2025-10-17T14:21Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$espr
Esperion Therapeutics ($ESPR) sees mixed signals as buyout rumors and Japan approval fuel optimism, but the recent public offering is causing some downward pressure. The stock is re-rating before our eyes.
About $espr
Esperion Therapeutics ($ESPR) is a pharmaceutical company focused on developing and commercializing oral, once-daily, non-statin therapies for the treatment of hypercholesterolemia.
Engagements: XXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
1-Year High: XXXXXX on 2025-08-04
1-Year Low: XX on 2025-09-15
| Social Network | X | YouTube |
|---|---|---|
| Engagements | XXX | XX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-15
| Social Network | X | YouTube |
|---|---|---|
| Mentions | XX | X |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $espr in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-15
The most influential creators that mention $espr in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @MACROVET888 | X | XXX | X | XX |
| @Bbrc424864Bbrc | X | XXX | X | XX |
| @stocket_rocket | X | XXX | X | XX |
| @msp12389 | X | XXXXX | X | XX |
| @BuyTheUgly | X | XX | X | XX |
| @rumourbuyouts | X | XXX | X | XX |
| @mariostario2019 | X | XX | X | XX |
| @TradershubNinja | X | XXXXX | X | X |
| @ChirpSavvy | X | XXX | X | X |
Sentiment: XXX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% +25%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-09-29
Most Supportive Themes
- Buyout Speculation and Price Targets: (40%) Positive sentiment around potential buyout offers from Otsuka, with analysts setting a $X price target.
- Japan Approval and Patent News: (30%) Positive sentiment around the Japan approval and the potential for a triple-combo patent.
- Patent Approval: (20%) Positive sentiment around the potential for a triple-combo patent.
Most Critical Themes
- Financial Strategy and Inventory Management: (10%) Concerns about potential delays in revenue recognition and the impact of inventory management on cash flow.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XXX | XX% | X | X% |
| YouTube | X | X% | XX | X% | X | X% |
| Total | XXX | XX% | XXX | XX% | X | X% |
Top assets mentioned In the posts about $espr in the last XX hours
Dave Inc. Class A Common Stock (DAVE) Moonft (MTC) NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) Agilon Health, Inc. (AGL) Agilon Health, Inc. (AGL) Elanco Animal Health Incorporated Common Stock (ELAN) CRISPR Therapeutics AG (CRSP) Landwolf (WOLF) Jigstack (STAK2) AST SpaceMobile, Inc. Class A Common Stock (ASTS)
Top topics mentioned In the posts about $espr in the last XX hours
coins made in usa, $gsun, stocks consumer cyclical, $4578t, discord, $dave, $4768t, $mtc, coins defi, japan, stocks healthcare, $cmnd, $nams, lack of, acquisition, agilon health inc, $agl, $sgd, coins layer 1, $elog, $120m, $elan, $crsp, $wolf, $benf, jigstack, coins dao, momentum, united states, $asts, $tmq, $pubm, $hoth, $spy, coins solana ecosystem, $zbio, primary market, flood, cracks, $107m, $114m, disco, $xbi, liver, uptrend, up the, bump, $phat, $300m, ipo, $mrm, $papl, $htfl, coins bsc, stocks technology, stocks industrials, $aapl, $aep, $colb, insurance, $450m, money, wall street, ecomi, coins base ecosystem, coins nft, coins gaming, $omi, $poet, $prgo, $slrx, $490s, $upc, $xbio, $acxp, $tgtx, $rcat, $onds, shah, $hubc, $spcb, $bidu, baidu, $9888hk, $peng, coins meme, $imxi, $sprb, $50m, $kpti, $rnaz, listing, china, $dgnx, $ntla, $apge, $crml, $200m2b, $kytx, $phoe
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$ESPR Management insisted the cash runway was solidclearly not. Lack of transparency is business as usual for this team. Either it was a poison pill to block a takeover or once the offering killed it they chose litigation instead"
X Link @Blueeee_Jay 2025-10-17T21:02Z XXX followers, XXX engagements
"$ESPR Sober Reflections Without Drama But Worth Considering These thoughts are prompted by several recent developments. On September XX 2025 BA received approval in Japan. According to the agreement Otsuka were to pay $XX million jupon first JNDA and up to $XX million upon achivement events "MACE" (see screenshot and details pricing-related milestones following inclusion on the NHI list). The payment timeline for these milestones is typically XX months after the event which implies a latest due date around November XX. Then we received the encouraging news about the Dr. Reddys settlement"
X Link @AndriiMart1 2025-10-17T20:04Z XX followers, 1002 engagements
"$ESPR soaked up the new share offering better than anticipated. Looks like we bump up against $XXXX -$3.50 once or twice more. Then run towards $XXXX. The stock is re-rating before our eyes"
X Link @Bbrc424864Bbrc 2025-10-17T19:43Z XXX followers, XXX engagements
"$ESPR $XBI ESPR starts selection ACLY for rare liver condition with potential Orphan Drug Status but more near term catalysts. As mentioned with past posts the new uptrend has started despite market instability. It is safe extremely undervalued"
X Link @MACROVET888 2025-10-17T14:21Z XXX followers, XXX engagements